In 2023, Sweden recorded the actual number of stem cell transplants performed in inpatient cases. From 2024 onwards, data is based on forecasts, showing a slight annual decrease. Specifically, in 2024, the value stands at 87.1, and by 2028, it drops to 86.3. On average, the year-on-year percentage decrease from 2024 to 2028 is minimal, representing a Continuous Average Growth Rate (CAGR) over the five years.
Future trends to watch for include advances in stem cell technology, healthcare policy changes, and the impact of demographics on the demand for stem cell procedures. Close attention should be paid to innovation in non-invasive techniques, which may influence these forecasts.
